The global pharmacovigilance market is on an accelerated growth trajectory, with its valuation expected to soar from USD 8,813.6 million in 2023 to an impressive USD 27,768.5 million by 2031. This remarkable expansion, characterized by a compound annual growth rate (CAGR) of 15.41% from 2024 to 2031, underscores the increasing emphasis on drug safety and regulatory compliance across...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian